This article has multiple issues. Please help improve it or discuss these issues on the talk page. ( Learn how and when to remove these template messages) This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources:  "Kank-A" –  news · newspapers · books · scholar · JSTOR (May 2014) This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources:  "Kank-A" –  news · newspapers · books · scholar · JSTOR (October 2015) ( Learn how and when to remove this message) ( Learn how and when to remove this message)

Kank-A is an American brand of liquid pharmaceutical product marketed by Blistex used primarily to treat canker sores. ^[1] It is applied directly on the sore and works by numbing the local area (with benzocaine) to prevent discomfort and forming a protective mucous barrier with a compound benzoin tincture that protects the ulcer from further irritation, allowing it to heal more rapidly.

As of 2014, Kank-A comes in two varieties, the original providing oral pain relief against canker sores, and a soft gel that provides oral pain relief of toothaches. ^[2]

This product article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e